Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
129 participants
INTERVENTIONAL
2008-09-30
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive Behavioral Stress Management
10 week program of Cognitive Behavioral Stress Management (CBSM) group sessions
Cognitive Behavioral Stress Management (CBSM)
10 week program of weekly CBSM therapy group sessions
Patient Education
10 week program of once weekly Patient Education group sessions
Patient Education
10 week program of "Patient Education" group sessions, involving presentations of educational materials relating to heart disease.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Behavioral Stress Management (CBSM)
10 week program of weekly CBSM therapy group sessions
Patient Education
10 week program of "Patient Education" group sessions, involving presentations of educational materials relating to heart disease.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ICD Implantation,
* \> 3 months following ICD implantation,
* willingness to give informed consent
Exclusion Criteria
* severe mental illness,
* life expectancy \< 1 year,
* hyperkalemia,
* hypokalemia,
* hypomagnesemia,
* hypermagnesemia,
* unwillingness to give informed consent
21 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
US Department of Veterans Affairs
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Douglas Russell, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Wlliam S. Middleton Memorial Veterans Hospital, Madison
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wlliam S. Middleton Memorial Veterans Hospital, Madison
Madison, Wisconsin, United States
Zablocki VA Medical Center, Milwaukee
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Russell DC, Smith TL, Krahn DD, Graskamp P, Singh D, Kolden GG, Sigmund H, Zhang Z. Effects of Cognitive Behavioral Stress Management on Negative Mood and Cardiac Autonomic Activity in ICD Recipients. Pacing Clin Electrophysiol. 2015 Aug;38(8):951-65. doi: 10.1111/pace.12668. Epub 2015 Jun 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLIN-008-07F
Identifier Type: -
Identifier Source: org_study_id